Lack of the Effect of Bumetanide, a Selective Nkcc1 Inhibitor, in Patients With Schizophrenia: A Double-Blind Randomized Trial

Lack of the Effect of Bumetanide, a Selective Nkcc1 Inhibitor, in Patients With Schizophrenia: A Double-Blind Randomized Trial Publisher Pubmed

Rahmanzadeh R¹ ; Shahbazi A² ; Ardakani MRK³ ; Mehrabi S¹ ; Rahmanzade R¹ ; Joghataei MT^{1, 2}

Show Affiliations

1. Division of Neuroscience, Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran
2. Faculty of Advanced Technologies in Medicine, Department of Neuroscience, Iran University of Medical Sciences, Tehran, Iran
3. Razi Psychiatric Hospital, University of Social Welfare and Rehabilitation, Tehran, Iran

Source: Psychiatry and Clinical Neurosciences Published:2017

Abstract

[No abstract available]

2. A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy, CNS Drugs (2019)

Experts (# of related papers)

View all Related Experts

Abbas Tafakhori (1)

Mahmoud Reza Hadjighassem (1)

Style	Citing Format
MLA	Rahmanzadeh R, et al.. "Lack of the Effect of Bumetanide, a Selective Nkcc1 Inhibitor, in Patients With Schizophrenia: A Double-Blind Randomized Trial." Psychiatry and Clinical Neurosciences, vol. 71, no. 1, 2017, pp. 72-73.
APA	Rahmanzadeh R, Shahbazi A, Ardakani MRK, Mehrabi S, Rahmanzade R, Joghataei MT (2017). Lack of the Effect of Bumetanide, a Selective Nkcc1 Inhibitor, in Patients With Schizophrenia: A Double-Blind Randomized Trial. Psychiatry and Clinical Neurosciences, 71(1), 72-73.
Chicago	Rahmanzadeh R, Shahbazi A, Ardakani MRK, Mehrabi S, Rahmanzade R, Joghataei MT. "Lack of the Effect of Bumetanide, a Selective Nkcc1 Inhibitor, in Patients With Schizophrenia: A Double-Blind Randomized Trial." Psychiatry and Clinical Neurosciences 71, no. 1 (2017): 72-73.
Harvard	Rahmanzadeh R et al. (2017) 'Lack of the Effect of Bumetanide, a Selective Nkcc1 Inhibitor, in Patients With Schizophrenia: A Double-Blind Randomized Trial', Psychiatry and Clinical Neurosciences, 71(1), pp. 72-73.
Vancouver	Rahmanzadeh R, Shahbazi A, Ardakani MRK, Mehrabi S, Rahmanzade R, Joghataei MT. Lack of the Effect of Bumetanide, a Selective Nkcc1 Inhibitor, in Patients With Schizophrenia: A Double-Blind Randomized Trial. Psychiatry and Clinical Neurosciences. 2017;71(1):72-73.
BibTex	@article{ author = {Rahmanzadeh R and Shahbazi A and Ardakani MRK and Mehrabi S and Rahmanzade R and Joghataei MT}, title = {Lack of the Effect of Bumetanide, a Selective Nkcc1 Inhibitor, in Patients With Schizophrenia: A Double-Blind Randomized Trial}, journal = {Psychiatry and Clinical Neurosciences}, volume = {71}, number = {1}, pages = {72-73}, year = {2017} }
RIS	TY - JOUR AU - Rahmanzadeh R AU - Shahbazi A AU - Ardakani MRK AU - Mehrabi S AU - Rahmanzade R AU - Joghataei MT TI - Lack of the Effect of Bumetanide, a Selective Nkcc1 Inhibitor, in Patients With Schizophrenia: A Double-Blind Randomized Trial JO - Psychiatry and Clinical Neurosciences VL - 71 IS - 1 SP - 72 EP - 73 PY - 2017 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract